|
Market Closed -
Nasdaq
04:00:00 24/06/2026 HKT
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.41B 5.08B 4.63B 8.71B 595B 8.76B 60.11B 23.4B 303B 23.53B 23.02B 1,003B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.25B 4.94B 4.5B 8.47B 578B 8.51B 58.42B 22.74B 294B 22.87B 22.37B 975B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +1.61% | ||
| 6 months | +50.78% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/6/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 1/5/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 26/3/26 | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +141.22% | +427.34% | 6.27B | |
| +0.21% | -2.69% | +1.19% | +17.32% | 49.74B | |
| +2.09% | -0.71% | +452.73% | +498.77% | 44.98B | |
| -1.09% | -0.41% | +35.40% | +15.17% | 42.52B | |
| -0.26% | -4.71% | +17.19% | +71.67% | 40.78B | |
| -0.48% | -0.84% | +16.25% | +49.80% | 32.89B | |
| -1.06% | +2.87% | - | - | 17.09B | |
| -1.81% | -5.02% | +22.65% | +113.24% | 16.28B | |
| -1.35% | -3.40% | +10.13% | +26.34% | 14.4B | |
| -2.05% | -5.14% | +72.89% | +34.69% | 13.48B | |
| Average | -0.66% | -2.01% | +85.51% | +139.37% | 27.84B | |
| Weighted average by Cap. | -0.47% | -2.18% | +97.75% | +129.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 12.94 12.17 11.09 20.85 1.42K 20.96 143.89 56 724.15 56.32 55.1 2.4K |
| Net income | -236M -203M -191M -174M -328M -22.37B -329M -2.26B -880M -11.38B -885M -866M -37.74B | -198M -170M -160M -146M -275M -18.75B -276M -1.89B -738M -9.54B -742M -726M -31.62B |
| Net Debt | -364M -314M -296M -269M -506M -34.58B -509M -3.49B -1.36B -17.59B -1.37B -1.34B -58.32B | -176M -152M -143M -130M -245M -16.72B -246M -1.69B -658M -8.51B -662M -647M -28.21B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
